*** RESULTS NOT TYPICAL. ENDORSER USED LIPOZENE^® IN COMBINATION WITH DIET AND EXCERCISE AND WAS RENUMERATED.

^▼ ORI SPONSORED AN 8 WK STUDY WHERE PARTICIPANTS WERE INSTRUCTED TO TAKE AMORPHOPHALLUS KONJAC (GLUCOMANNAN) THE ACTIVE INGREDIENT IN LIPOZENE, BUT WERE NOT GIVEN INSTRUCTION AS TO DIET/EXERCISE OR LIFESTYLE CHANGES. ON AVG, THE COMPLIANT ACTIVE SUBGROUP LOST 4.93 MORE LBS THAN PLACEBO AND AT LEAST 78% OF WEIGHT LOSS WAS BODY FAT. YOUR RESULTS MAY VARY. ORI ALSO RELIES UPON THE GENERAL BODY OF SCIENTIFIC EVIDENCE AND STUDIES RELATED TO AMORPHOPHALLUS KONJAC (GLUCOMANNAN). THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FDA. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE. 4X WEIGHT LOSS CLAIM BASED ON AN 8 WK CLINICAL STUDY THAT SHOWED FOUR TIMES MORE WEIGHT LOSS ON A PER POUND BASIS IN STUDY PARTICIPANTS TAKING ACTIVE INGREDIENT VERSUS PLACEBO.

* ALL ORI PRODUCT SHIPPED FROM THE MANUFACTURER ARE ASSESSED A $1.35 PROCESSING FEE AND HAVE A 30 DAY MONEY BACK GUARANTEE EXCLUDING $1.35 FOR PROCESSING.

** USE ONLY AS DIRECTED. CONSULT YOUR HEALTHCARE PROVIDER PRIOR TO TAKING THIS OR ANY OTHER SUPPLEMENT OR MEDICATION, EITHER OVER THE COUNTER OR PRESCRIPTION, OR STARTING THIS OR ANY OTHER WEIGHT LOSS REGIMEN. IF YOU ARE PREGNANT OR LACTATING, DO NOT TAKE THIS PRODUCT.

• BASED ON IRI SINGLE SKU SALES DATA, OCTOBER 4, 2015.

† THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FDA, THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE.